info@synchemia.com | sales@synchemia.com 
9766925136 
Safinamide
Safinamide | CAS NO: 133865-89-1, Safinamide is a medication used primarily in the treatment of Parkinson’s disease, particularly in patients experiencing “off” episodes while taking levodopa or other dopaminergic therapies.
We are the Synchemia Research Chemical specializes in manufactures (EP/BP/USP/IP) as well as process-related impurities Indication: Adjunct treatment for Parkinson’s disease patients experiencing motor fluctuations (i.e., "off" episodes) despite being on a stable dose of levodopa. When added to levodopa: Increases "on" time without troublesome dyskinesia. Decreases "off" time (periods when medication wears off and symptoms return). Buy Reliable and High-Purity Safinamide Impurities, Delivered by Synchemia Research Chemicals.
Download catalogue
Pharmaceutical Reference Standards
| CAT No | SRC-S19341 |
| CAS No | 133865-89-1 |
| Mol.F. | C17H19FN2O2 |
| Mol.Wt. | 302.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-S19342 |
| CAS No | 1843368-38-6 |
| Mol.F. | C10H14N2O2 |
| Mol.Wt. | 194.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-S19343 |
| CAS No | 1000370-24-0 |
| Mol.F. | C21H16F2O2 |
| Mol.Wt. | 338.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-S19344 |
| CAS No | 866149-39-5 |
| Mol.F. | C17H17FN2O2 |
| Mol.Wt. | 300.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-S19345 |
| CAS No | 66742-57-2 |
| Mol.F. | C14H11FO2 |
| Mol.Wt. | 230.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-S19346 |
| CAS No | NA |
| Mol.F. | C23H22F2N2O2 |
| Mol.Wt. | 396.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-S19347 |
| CAS No | 405-85-6 |
| Mol.F. | C14H11FO3 |
| Mol.Wt. | 246.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-S19348 |
| CAS No | NA |
| Mol.F. | C17H17FN2O2 |
| Mol.Wt. | 300.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-S19349 |
| CAS No | NA |
| Mol.F. | C20H19FO9 |
| Mol.Wt. | 422.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-S19350 |
| CAS No | NA |
| Mol.F. | C17H16D3FN2O2 |
| Mol.Wt. | 305.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-S19351 |
| CAS No | 2270245-27-5 |
| Mol.F. | C17H19FN2O3 |
| Mol.Wt. | 318.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-S19352 |
| CAS No | 1827614-91-4 |
| Mol.F. | C18H20FNO3 |
| Mol.Wt. | 317.4 g/mol |
| INV STATUS | IN STOCK |
| CAT No | SRC-S19353 |
| CAS No | 1160513-60-9 |
| Mol.F. | C17H18FNO3 |
| Mol.Wt. | 303.3 g/mol |
| INV STATUS | IN STOCK |
| CAT No | SRC-S19354 |
| CAS No | 202825-43-2 |
| Mol.F. | C17H19FN2O2 |
| Mol.Wt. | 302.3 g/mol |
| INV STATUS | IN STOCK |
| CAT No | SRC-S19355 |
| CAS No | 690969-16-5 |
| Mol.F. | C14H13FO2 |
| Mol.Wt. | 232.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-S19356 |
| CAS No | 174756-44-6 |
| Mol.F. | C17H19FN2O2 |
| Mol.Wt. | 302.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
Let’s advance your research together.
Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.
